LUXAI SA

Their core work

LUXAI SA is a Luxembourg-based technology SME specializing in social and assistive robotics, with QTrobot as their flagship commercial product — a programmable humanoid robot designed specifically for autism spectrum disorder therapy and special education. They translate robotics research into deployable therapeutic tools that can be operated by therapists, teachers, and caregivers without deep technical knowledge. Beyond their robotics core, their participation in the SecureIoT project demonstrates competency in IoT device security and predictive threat detection for connected platforms. As a product company rather than a pure research lab, they bring market-ready technology into EU research consortia rather than theoretical expertise alone.

What they specialise in

How they've shifted over time

Both H2020 projects began in 2018, meaning there is effectively no temporal window across which to trace an evolution — LUXAI's entire EU project record falls within a single calendar year. What the data does reveal is a company operating on two parallel tracks simultaneously: commercializing their own assistive robot product through an SME grant while plugging specialist IoT capabilities into a larger research consortium. No keyword metadata was available to enrich this picture, so any claim of directional shift would be speculative rather than data-grounded.

Given that QTrobot is LUXAI's proprietary named product and they held the coordinator role on that grant, their most probable trajectory is scaling assistive robotics for special education and therapy markets — with IoT security as a secondary competency that could support smart device integration in clinical environments.

How they like to work

LUXAI has taken both lead and support roles in EU projects: coordinating their own product-focused SME grant and joining a larger multi-partner RIA as a specialist contributor. With 20 unique consortium partners across 10 countries drawn from only two projects, they engage with unusually broad international networks relative to their size. As a small product company, they likely contribute a deployable technology asset — the QTrobot platform — rather than research management or large-scale infrastructure in multi-partner settings.

LUXAI has connected with 20 consortium partners across 10 countries through just two projects, indicating active engagement with diverse European research and industry networks. No geographic concentration is evident from the data, suggesting a pan-European rather than regionally clustered collaboration pattern.

What sets them apart

LUXAI occupies a narrow but commercially significant niche as one of very few European SMEs with a market-ready humanoid robot product validated specifically for autism therapy — an application with strong demand from schools, clinics, and therapy centers but limited specialist suppliers. For consortium builders, they offer something rare: a deployable product platform that can be integrated into research pilots without requiring custom hardware development. Their dual footprint in assistive robotics and IoT security also makes them a credible partner in projects combining human-robot interaction with connected device infrastructure.

Highlights from their portfolio

• QTrobot
  LUXAI coordinated this project under their own product name, making it the clearest signal of their commercial identity and their commitment to bringing assistive robotics to the autism therapy market.
• SecureIoT
  With €270,118 in EC funding — the largest grant LUXAI received — this RIA project demonstrates their capacity to contribute IoT security expertise within a substantial multi-partner research consortium.